IL2 and acute myeloid leukemia: This, in combination with previously published (38, 39, 70) and ongoing studies within our group, now defines an important limitation of studying human IL-2/zoledronic acid-expanded γδ T cells in the murine setting, as these cells do not migrate to the bone marrow, which is the site of later stage CMK cell growth in this AML mouse model.